J B Chemicals and Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis

JBCHEPHARM Pharmaceuticals
Screen J B Chemicals and Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1840.20
▼ -10.20 (-0.55%)
2026-01-05 00:00:00
Share Price BSE
₹1836.60
▼ -11.20 (-0.61%)
2026-01-05 00:00:00
Market Cap ₹28,478.59 Cr.
P/E Ratio (TTM) 15.00
P/B Ratio 7.47
EPS (TTM) ₹42.45
Dividend Yield 0.85%
Debt to Equity 0.06
52W High ₹1896.40
52W Low ₹1504.40
Operating Margin 24.00%
Profit Margin 15.15%
Revenue (TTM) ₹964.00
EBITDA ₹241.00
Net Income ₹146.00
Total Assets ₹4,274.00
Total Equity ₹3,433.00
Last updated: Jan 06, 2026

J B Chemicals and Pharmaceuticals Share Price History - Stock Screener Chart

Screen JBCHEPHARM historical share price movements with interactive charts. Analyze price trends and patterns.

J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener

Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JBCHEPHARM shares.
J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. The company has manufacturing facilities in various locations in India and maintains a direct presence in Russia and South Africa, with distributor relationships in the US and other international markets. In 2020, Tau Investment Holdings Pte. Ltd., an affiliate of KKR, acquired a controlling stake in the company. J.B. Chemicals & Pharmaceuticals continues to expand its product portfolio through new launches and acquisitions in various therapeutic segments.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
Chairperson/CEO Arun Duggal
ISIN INE572A01036
Website https://www.jbpharma.com

J B Chemicals and Pharmaceuticals Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 4,274 3,994 3,554 2,607 2,238 1,821 1,792 1,765 1,674 1,648
Current Assets 1,923 1,853 1,528 1,253 1,553 1,073 1,051 1,047 795 816
Fixed Assets 1,968 2,004 1,901 1,277 634 651 621 640 679 440
Liabilities
Total Liabilities 4,274 3,994 3,554 2,607 2,238 1,821 1,792 1,765 1,674 1,648
Current Liabilities 208 203 519 85 79 69 65 46 27 31
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 3,433 2,923 2,480 2,139 1,813 1,438 1,483 1,444 1,366 1,186
Share Capital 16 16 16 16 16 16 16 17 17 17
Reserves & Surplus 3,418 2,908 2,465 2,119 1,794 1,420 1,464 1,425 1,347 1,167

J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Intrinsic Value
Screen JBCHEPHARM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept 2022-Dec
Revenue 964 1,109 1,100 878 1,010 1,011 972 767 902 889 852 627 786 811 796
Expenses 723 793 775 664 724 730 709 599 664 638 621 500 612 625 618
EBITDA 241 315 325 215 286 281 263 168 238 251 231 127 174 186 178
Operating Profit % 24.00% 28.00% 29.00% 23.00% 28.00% 27.00% 26.00% 21.00% 26.00% 28.00% 26.00% 20.00% 22.00% 23.00% 22.00%
Depreciation 46 43 44 41 41 42 42 32 31 32 34 22 26 28 28
Interest 2 1 1 9 6 2 3 14 12 10 13 2 6 8 8
Profit Before Tax 193 272 279 165 240 237 218 123 194 209 184 103 142 150 141
Tax 47 69 71 38 63 62 56 35 52 58 50 18 37 39 35
Net Profit 146 202 208 126 177 175 163 88 142 151 134 85 105 111 106
EPS 9.36 12.99 13.29 8.22 11.39 11.24 10.46 11.33 9.20 9.72 8.62 10.98 13.59 14.37 13.72

J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 903 801 626 170 315 276 194 123 201 140
Investing Activities -296 -404 -962 2 -231 24 -28 -21 -45 -26
Financing Activities -580 -386 357 -138 -87 -306 -156 -60 -184 -100
Net Cash Flow 27 11 20 34 -3 -6 11 43 -28 15

J B Chemicals and Pharmaceuticals Shareholding Pattern Screener - Ownership Analysis

Screen JBCHEPHARM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 47.84% 47.73% 47.56% 53.78% 53.77% 53.74% 53.66% 53.93%
FII Holding 18.30% 17.77% 15.30% 11.06% 12.17% 13.63% 14.64% 0.00%
DII Holding 18.72% 19.63% 22.83% 18.38% 17.62% 16.81% 16.41% 19.08%
Govt Holding 0.00% 0.00% 0.00% 0.01% 0.00% 0.01% 0.00% 0.00%
Public Holding 13.28% 13.04% 12.47% 14.69% 14.38% 13.87% 13.42% 15.98%
Other Holding 1.86% 1.83% 1.84% 2.09% 2.05% 1.94% 1.87% 11.00%
Shareholder Count 63,948 70,064 71,957 63,892 66,953 62,743 62,081 56,633

J B Chemicals and Pharmaceuticals Dividend Screener - Share Yield Analysis

Screen JBCHEPHARM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Period Dividend Per Share Dividend Yield
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹17.75 1.08%
2022-March ₹16.50 1.67%
2021-March ₹16.50 2.10%
2020-March ₹11.00 1.75%
2019-March ₹5.00 1.96%
2018-March ₹2.00 1.10%
2017-March ₹1.00 0.64%
2016-March ₹5.00 2.89%

J B Chemicals and Pharmaceuticals Index Membership - Market Screener Classification

Screen JBCHEPHARM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions

Screen JBCHEPHARM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
2023-05-24 Split 1:2 0.00%
Dividend ₹ 8.00 /share 10.40%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 6.12%
2025-08-06 2025-08-06 Annual General Meeting NA 4.95%
2025-07-30 2025-07-30 Quarterly Result Announcement NA 9.13%
2025-07-30 2025-07-30 Dividend ₹ 7.00 /share 14.10%
2025-05-14 2025-05-14 Quarterly Result Announcement NA -4.75%
2025-02-07 2025-02-08 Dividend ₹ 8.50 /share -2.35%
2025-02-04 2025-02-04 Quarterly Result Announcement NA -5.04%
2024-11-06 2024-11-06 Quarterly Result Announcement NA -2.31%
2024-08-21 2024-08-21 Annual General Meeting NA 8.60%
2024-08-14 2024-08-14 Dividend ₹ 6.75 /share 5.95%
2024-02-16 2024-02-16 Dividend ₹ 5.50 /share -2.58%
2023-08-17 2023-08-17 Dividend ₹ 9.25 /share 34.74%
2023-02-17 2023-02-18 Dividend ₹ 8.50 /share -2.56%

J B Chemicals and Pharmaceuticals Competitors Screener - Peer Comparison

Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 412,566 39.76 54,729 9.71% 10,980 38.51
Divis Laboratories 170,630 69.39 9,712 18.67% 2,191 49.65
Torrent Pharmaceuticals 129,171 60.64 11,539 6.99% 1,911 59.81
Cipla 121,648 22.24 28,410 7.12% 5,291 47.65
Dr Reddys Laboratories 105,938 18.42 33,741 16.73% 5,725 51.90
Lupin 96,485 22.16 22,910 13.74% 3,306 59.99
Zydus Life Science 91,723 18.36 23,511 18.55% 4,615 38.57
Mankind Pharma 90,518 51.06 12,744 20.90% 2,007 47.23
Aurobindo Pharma 70,056 20.59 32,346 9.43% 3,484 53.21
Alkem Laboratories 66,179 27.60 13,458 3.70% 2,216 42.41

J B Chemicals and Pharmaceuticals Company Announcements - News Screener

Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-02 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-01-01 DJSI (Dow Jones Sustainable Index) ESG Score Release View
2025-12-16 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of Order View
2025-12-09 Updates on Open Offer View
2025-12-06 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2025-11-23 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2025-11-17 Updates on Open Offer View
2025-11-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-11-14 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2025-11-12 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-11-12 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-11 Announcement under Regulation 30 (LODR)-Investor Presentation View
2025-11-11 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-11-11 Board Meeting Outcome for Outcome Of Board Meeting View
2025-11-07 Letter of Offer View
2025-10-31 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-10-31 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-10-31 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-10-24 4Th Sustainability (ESG) Report View
Back to Screener